Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing its own internal pipeline.Founded in September 2019, they are a team of experienced AI/machine learning and business specialists applying state of the art generative AI to drug discovery in close collaboration with biopharmaceutical partners to bring new therapeutics to market across disease areas and positively impact lives.
B2B
1 to 25
Seed
$3,500,000
Scaling Up
2019
Pharmaceuticals
Medical Practice
N/A
N/A
N/A
Yes
Active
Machine Learning
N/A
N/A
Software
3
1
$3.4M
Company was founded 2019 and it took almost 2 years (Nov 2021) to raise first external round
Investors
Interested in researching Variational AI?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Variational AI
Potential Customers
Interested in what they do or partnership?
Learn more about how they work